Table 1. Performance of serum marker panels to assess liver fibrosis/cirrhosis in HIV/HCV co-infected patients, 2010-2011.
≥F2 (significant fibrosis) | ≥F3 (advanced fibrosis) | ≥F4 (cirrhosis) AUROC | |||||||
---|---|---|---|---|---|---|---|---|---|
≥F2 (significant fibrosis) | ≥F3 (advanced fibrosis) | ≥F4 (cirrhosis) AUROC | |||||||
| |||||||||
Score | Serum Markers | Reference | N | % | AUROC | % | AUROC | % | AUROC |
Direct | |||||||||
Hyaluronic acid (HA) | [9] | 201 | 58 | 0.67 | 32 | 0.77 | 11 | 0.86 | |
Matrix metalloproteinase 2 (MMP-2) | [10] | 90 | 66 | 0.64 | 37 | --- | 18 | 0.79 | |
Tissue inhibitor of metalloproteinase-1 (TIMP-2) | [10] | 90 | 66 | 0.57 | 37 | --- | 18 | 0.64 | |
| |||||||||
Indirect | |||||||||
APRI | Platelets, AST | [9,11-17]A | 2025B,C | 43-81 | 0.67-0.79 | 15-34 | 0.76-0.82 | 8-20 | 0.80 |
FIB-4 | Age, Platelets, AST, ALT | [9,11-15,17]A | 1506B,C | 43-81 | 0.67-0.76 | 15-34 | 0.69-0.85 | 8-20 | 0.82 |
Forns Index | Age, Platelets, GGT, Cholesterol | [9,13-16] | 1178 | 43-58 | 0.67-0.74 | 15-32 | 0.75-0.78 | 8-12 | 0.82 |
HGM-1 | Platelets, AST, Glucose | [9,14,15] | 563 | 57-58 | 0.78-0.80 | 27-32 | --- | 11 | --- |
HGM-2 | Platelets, AST, Alkaline Phosphatase, INR, | [9,13-15] | 659 | 43-58 | --- | 15-32 | 0.80-0.85 | 8-11 | 0.92 |
HICV | Alpha-2-macroglobulin, AST, Prothrombin Index | [17]A | 444 | 66-72 | 0.73-0.82 | 33-34 | --- | 10-20 | --- |
Artificial Neuronal Network (ANN) | Fibrinogen, glucose, AST, ALT, GGT, ALP, cholesterol, platelet count, INR, age | [14] | 362 | 56 | 0.85 | 27 | 0.87 | 11 | --- |
Direct & Indirect | |||||||||
HGM-3 | Platelets, Alkaline Phosphatase, HA, TIMP-1, Hepatocyte growth factor (HGF) | [15] | 195 | 58 | 0.78 | 31 | 0.93 | 12 | 0.93 |
Fibrometer | Age, Sex, Alpha-2-macroglobulin Platelets, AST, HA, Prothrombin Index, Urea | [17]A | 444 | 66-72 | 0.74-0.78 | 33-34 | --- | 10-20 | --- |
Fibrometer HICV | Age, Sex, Alpha-2-macroglobulin Platelets, AST, HA, Prothrombin Index, Urea | [17]A | 275 | 66-72 | 0.74-0.83 | 33-34 | --- | 10-20 | --- |
Fibrometer 2G | Age, Sex, Alpha-2-macroglobulin Platelets, AST, HA, Prothrombin Index, Urea | [18] | 176 | 67 | 0.82 | 33 | --- | 20 | ---- |
Fibrometer 3G | Age, Sex, Alpha-2-macroglobulin Platelets, AST, Prothrombin Index, Urea | [18] | 176 | 67 | 0.83 | 33 | --- | 20 | ---- |
Hepascore | Age, Sex, Alpha-2-macroglobulin, GGT, Bilirubin, Hyaluronic acid (HA) | [17]A | 444 | 66-72 | 0.69-0.78 | 33-34 | --- | 10-20 | --- |
Includes data from derivation and validation populations.
Liver fibrosis stage was assessed using the Batts-Ludwig system for 105 samples
Data included from 295 biopsies sampled from 237 patients. Liver fibrosis stage was assessed using the Ishak Histologic Activity Index (HAI) and Ishak 4–6 fibrosis represented advanced fibrosis corresponding to Metavir >F3.